Results 171 to 180 of about 1,915,304 (214)

Drug-coated Balloons in the Treatment of Coronary Artery Disease: Results from the Drug Eluting Technologies Evaluation & Current Trends (DETECT) Survey. [PDF]

open access: yesInterv Cardiol
O'Callaghan D   +9 more
europepmc   +1 more source

Ultrathin-strut drug-eluting stents are associated with lower revascularization rates than drug-coated balloons in non-focal in-stent restenosis. [PDF]

open access: yesFront Cardiovasc Med
Keskin B   +13 more
europepmc   +1 more source

Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions

Journal of Endovascular Therapy, 2020
Purpose: To evaluate the safety and efficacy of the novel SELUTION sustained-limus-release (SLR) drug-eluting balloon (DEB) in the treatment of femoropopliteal lesions.
T. Zeller   +5 more
semanticscholar   +1 more source

Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.

open access: yesJACC: Cardiovascular Interventions, 2017
The aim of this study was to compare neointimal modification with scoring balloon pre-dilation before drug-coated balloon (DCB) versus DCB standard therapy in patients presenting with drug-eluting stent (DES) restenosis.DCB angioplasty for the treatment ...
Robert A Byrne   +2 more
exaly   +2 more sources

Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions

open access: yesVascular, 2018
Objective The aim of this study was to compare the drug-eluting balloon with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.
Burak Teymen   +3 more
semanticscholar   +2 more sources

Drug-eluting balloon versus plain balloon angioplasty for the treatment of failing hemodialysis access: a systematic review and meta-analysis.

Annals of Vascular Surgery, 2020
PURPOSE To perform a meta-analysis comparing target lesion primary patency rates at 6 months and 1 year, and major procedure-associated complications between drug-eluting balloon (DEB) and plain balloon angioplasty (PBA) for the treatment of ...
Ye Yuan, W. Cheng, Huijun Lu
semanticscholar   +1 more source

The SELUTION SLR™ drug-eluting balloon system for the treatment of symptomatic femoropopliteal lesions.

Future Cardiology, 2020
Endovascular treatment has become first line therapy for the treatment of femoropopliteal disease. Drug-coated devices play a key role in maintaining vessel patency.
Tanja Böhme   +4 more
semanticscholar   +1 more source

A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. [PDF]

open access: yesJournal of the American College of Cardiology, 2012
ObjectivesThis study sought to define the impact of paclitaxel-coated balloon angioplasty for treatment of drug-eluting stent restenosis compared with uncoated balloon angioplasty alone.BackgroundDrug-coated balloon angioplasty is associated with ...
Hans-Josef Feistritzer   +1 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy